Stocks
Vanda Pharmaceuticals (VNDA) EV/EBITDA US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| EV/EBITDA | ? | 10.0 | -50.3 | 34.6 | 2.57 | -1.93 | -1.25 | |
| Changes by years, y/y, % | -4% | -602% | -169% | -93% | -175% | |||
Vanda Pharmaceuticals. EV/EBITDA
Vanda Pharmaceuticals. EV/EBITDA, changes, %
Vanda Pharmaceuticals (VNDA) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV/EBITDA | ? | 1.07 | 0.44 | -0.11 | -2.11 | -1.55 | -1.25 | |
| Changes by years, y/y, % | -94% | -97% | -103% | -183% | -245% | |||
| Changes by quarters, q/q, % | -58% | -59% | -125% | +1 862% | -27% | |||
